Clinical features of inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 16, Issue 4, 2000, Pages 329-336

  Allez, Matthieu ^a   Modigliani, Robert ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ARTICLE; CANCER RISK; CLINICAL FEATURE; COLON BIOPSY; CROHN DISEASE; DIGESTIVE SYSTEM CANCER; DISEASE ACTIVITY; DOPPLER FLOWMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSPLASIA; ENDOSCOPY; ENTERITIS; HUMAN; HYPERHOMOCYSTEINEMIA; MESENTERY BLOOD FLOW; OSTEOPENIA; QUALITY OF LIFE; THROMBOSIS; ULCERATIVE COLITIS;

EID: 0034465751     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200007000-00007     Document Type: Article

References (78)

1. Frequency and clinical evolution of indeterminate colitis: A retrospective multi-centre study in northern Italy
2. Endoscopic and histological patchiness in treated ulcerative colitis
3. Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: An analysis in relation to medical therapy and disease extent
4. A prospective evaluation of high resolution sonography in the diagnosis of inflammatory bowel disease
5. Ultrasound examination of the small bowel: Comparison with enteroclysis in patients with Crohn disease
6. Diagnostic value of high resolution sonography in the diagnosis of Crohn's disease and ulcerative colitis
7. Prospective evaluation of transabdominal bowel sonography in the diagnosis of intestinal obstruction in Crohn's disease: Comparison with plain abdominal film and small bowel enteroclysis
8. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease
9. Spiral CT of the abdomen after distention of small bowel loops with transparent enema in patients with Crohn's disease
10. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease
11. Cytomegaloviral enterocolitis: Clinical associations and outcome
12. Cytomegalovirus infection in patients with inflammatory bowel disease
13. Colitis in chronic granulomatous disease resembling Crohn's disease: Comparative analysis of CD68-positive cells between two disease entities
14. The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: A review of instruments to assess Crohn's disease
15. Controversies in IBD
16. Assessing activity of pediatric Crohn's disease: Which index to use?
17. Development and validation of an ultrasonographic activity index of Crohn's Disease
18. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: A prospective follow-up study
19. Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: A prospective followup study
20. Development and subsequent refinement of the inflammatory bowel disease questionnaire: A quality-of-life instrument for adult patients with inflammatory bowel disease
21. Development of a quality-of-life index for pediatric inflammatory bowel disease: Dealing with differences related to age and IBD type
22. Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: A prospective study
23. Health-related quality of life in patients with Crohn's disease: Influence of surgical operation: A prospective trial
24. Perforating and non-perforating indications for repeated operations in Crohn's disease: Evidence for two clinical forms
25. Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease
26. Intestinal permeability test as predictor of clinical course in Crohn's disease
27. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse
28. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
29. Faecal parameters in the assessment of activity in inflammatory bowel disease
30. Prediction of relapse in IBD and small intestinal permeability
31. Pregnancy outcome in inflammatory bowel diseases
32. Perianal Crohn's disease and pregnancy: Role of the mode of delivery
33. Hepatobiliary manifestations of inflammatory bowel disease
34. Primary sclerosing cholangitis (PSC): Clinical, laboratory and survival analysis in children and adults
35. Primary sclerosing cholangitis
36. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis
37. Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease
38. Rheumatologic manifestations of gastrointestinal diseases
39. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history
40. Extraintestinal manifestations of ulcerative colitis following restorative proctocolectomy
41. Fibromyalgia in IBD
42. SAPHO syndrome: A long-term follow-up study of 120 cases
43. Bones and Crohn's: Problems and solutions
44. Metabolic bone disease in adults with IBD
45. Bone mineral metabolism in pediatric IBD
46. Prevention and treatment of osteoporosis in patients with IBD
47. Growth in Crohn's disease
48. Ultrasound measurements of calcaneus for estimation of skeletal status in patients with IBD
49. Bone mineral density in children and young adults with Crohn's disease
50. Evolution of osteopenia in IBD
51. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: A case-control cross-sectional study of 113 patients
52. Osteopenia and osteoporosis in patients with inflammatory bowel disease (IBD): Evaluation by disease type and the response to alendroate therapy
53. The incidence of hip fracture and spine among patients with IBD: A population-based study
54. Inflammatory bowel disease in pediatric and adolescent patients
55. Bone loss in patients with IBD is less than expected: A follow-up study
56. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on chronic obstructive pulmonary disease
57. The pathogenesis of osteonecrosis and the relationships to corticosteroids
58. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease
59. Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease
60. Arteriosclerosis: Low folate levels and thermolabile methylenetetrahydrofofate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects
61. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications
62. Cancer risk in patients with inflammatory bowel disease
63. Cancer and inflammatory bowel disease: Bias, epidemiology, surveillance, and treatment
64. Increased risk of cancer in ulcerative colitis: A population-based cohort study
65. Intestinal adenocarcinoma in Crohn's disease: A report of 30 cases with a focus on coexisting dysplasia
66. Carcinoma arising in Crohn's disease fistulae: Another concern warranting another type of surveillance
67. Dysplasia in inflammatory bowel diseases: Definition and clinical impact
68. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: A clinical, pathological, and molecular review
69. Polypoid dysplasias in ulcerative colitis and sporadic adenomas: Genetic approach to the differential diagnosis
70. P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: An immunohistochemical study
71. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: A comparative immunohistochemical study
72. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
73. Acute major gastrointestinal hemorrhage in inflammatory bowel disease
74. Acute lower gastrointestinal bleeding in Crohn's disease: Characteristics of a unique series of 34 patients
75. Chronic interstitial nephritis due to 5-aminosalicylic acid
76. An audit of gastroduodenal Crohn disease: Clinicopathologic features and management
77. Epidemiology and the natural course of inflammatory bowel disease
78. Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease